BLOG/🇺🇸United States/broad market··daily

US Material Events SEC 8-K Filings — April 30, 2026

Material Events Monitor

50 high priority50 total filings analysed

Executive Summary

Across 50 filings from April 30, 2026, a dominant theme is extensive executive leadership changes, with 15+ CFO/President/Director appointments or transitions (e.g., BONK, Regional Health, Entegris, Eos Energy), signaling strategic pivots amid growth ambitions in tech, energy, and real estate. Period-over-period trends show mixed Q1 2026 results: revenue growth in 6/10 reporters (e.g., CCC +12% YoY, Kirby +7.5% YoY), but declines in others (ProPetro -7% QoQ revenue, BayFirst loans -14.2% YoY); margins varied with EBITDA expansions (CCC +21% YoY) offset by compressions (Kirby distribution -60 bps). M&A/divestitures were prolific (7 deals, e.g., MARA $1.5B acquisition adding 65% capacity, FTAI $1.52B sale delevering $1.16B debt), alongside financing upsizes (FTAI Aviation $400M to $2.025B revolver). Capital allocation leaned shareholder-friendly (dividends, buybacks like Kirby $52.7M), with annual meetings overwhelmingly approving equity plans/auditors (e.g., Chemours 95-99% support). No widespread insider selling; one CEO buy (Greenpro). Implications: Bullish for energy/infra growth plays, caution on small-cap financials with losses, catalysts cluster in H2 2026 M&A closings.

Tracking the trend? Catch up on the prior US Material Events SEC 8-K Filings digest from April 23, 2026.

Investment Signals(12)

  • BONK, INC.(BULLISH)

    Founder Mitchell Rudy appointed President to drive profitability, 5% BONK asset accumulation, digital pivot into RWA/prediction markets

  • Revolver expanded $400M to $2.025B (oversubscribed), maturity to 2031, improved pricing reflecting lender confidence

  • All-stock merger with ACRES Capital to double AUM to $4.7B, accretive to earnings/dividends, mgmt ownership >45%

  • $1.5B acquisition adds 505MW capacity (+65% to 2.2GW), $144M annualized EBITDA at <$15/MWh costs, H2 close

  • $1.52B sale eliminates $1.16B debt, repays $300M corporate debt for deleveraging/reinvestment

  • Kirby Corp(BULLISH)

    Q1 EPS +13% YoY to $1.50, revenue +7.5% YoY, coastal marine +23% YoY; FY EPS growth guidance raised to 5-15%, $52.7M buybacks

  • Q1 revenue +12% YoY to $281.3M, adj. EBITDA +21% YoY to $120.2M amid CFO transition

  • $950M asset sale yields $900M net cash toward $1B+ divestiture target, full $819M 2026 notes redemption

  • CEO subscribed $250K for 107k shares at $2.33, boosting ownership to 21.4% aggregate

  • Q1 diluted EPS +162% YoY to $0.34, $5M buybacks at $16.13/share, $0.06 dividend; pro-forma BV $23.80 post-sales

  • $19.5M Cataneo acquisition adds €6B ad inventory platform, funded non-dilutively, close June 30

  • Revolver commitments +$125M via amendment, enhances liquidity with no covenant breaches

Risk Flags(10)

Opportunities(10)

Sector Themes(6)

  • Executive Churn in Small-Mid Caps

    20/50 filings (40%) detail CFO/leadership changes (e.g., Entegris, Eos, Regional Health positive appointments; Matrix, NeuroOne neutral departures), implying strategic refreshes but transition risks; monitor Q2 execution.

  • Energy/Infrastructure M&A Surge

    5 deals (MARA $1.5B +65% capacity, FTAI $1.52B sale, SM Energy $950M divestiture, ProPetro Caterpillar framework for 2.1GW), boosting EBITDA/capacity; sector poised for H2 catalysts amid power demand.

  • Mixed Q1 Financials in Reporting Cos

    7/10 with data show revenue growth avg +8% YoY (Kirby +7.5%, CCC +12%) but EBITDA/margins volatile (ProPetro -29% QoQ, BayFirst losses widening); outperformers in marine/tech, laggards in banking/oilfield.

  • Financing Expansions Prevalent

    8 amendments/upsizes (FTAI Aviation x5 to $2B, Phibro +$125M, NexPoint term loan), signaling lender support/deleveraging; REITs/banks active (ACRES, Camden ATM $500M).

  • Shareholder-Friendly Capital Alloc

    Dividends (BorgWarner $0.17, Tiptree $0.06), buybacks (Kirby $52.7M, Tiptree $5M), equity plans approved at AGMs (Chemours 6.4M shares, RLJ 4.8M); contrasts M&A dilution risks.

  • Board Refresh at AGMs

    10/50 annual meetings with 95%+ approvals for directors/auditors/equity plans (Chemours 99%, Armour REIT strong), low dissent signals alignment.

Watch List(8)

Filing Analyses(50)
TELA Bio, Inc.8-Kneutralmateriality 7/10

30-04-2026

TELA Bio, Inc. furnished preliminary unaudited financial data for the quarter ended March 31, 2026, noting it is subject to change upon financial closing procedures and not audited by KPMG LLP, with full results to be in the upcoming 10-Q. Multiple directors including Chairman Doug Evans, Kurt Azarbarzin, Vince Burgess, and Federica O’Brien will resign effective after the 2026 Annual Meeting, while Joseph Capper is nominated as new non-independent Chairman and Guido Neels, Guy Nohra, and Paul Thomas are appointed as independent directors with committee roles. No specific financial metrics were disclosed, and none of the departures stem from disagreements on company matters.

  • ·Resignations effective immediately following 2026 Annual Meeting; no disagreements with company.
  • ·Joseph Capper not independent under Nasdaq rules; Incoming Directors (Neels, Nohra, Thomas) are independent.
  • ·Equity awards to new directors: options for 17,550 shares (36 monthly installments) and RSUs for 11,925 shares (3 annual installments), effective June 9, 2026.
  • ·Committee assignments: Neels (Compensation, Nominating); Nohra (Audit, Chair Compensation); Thomas (Audit, Chair Nominating).
  • ·Preliminary Q1 2026 financials unaudited, not reviewed by KPMG, not for reliance.
BONK, INC.8-Kpositivemateriality 8/10

30-04-2026

Bonk, Inc. (NASDAQ:BNKK) appointed founder Mitchell Rudy (Nom) as President, while he retains his Board seat, to drive a three-pillar mandate: path to profitability via high-margin digital revenue, targeted accumulation to 5% ownership of BONK digital asset supply, and direct business incubation. The company is expanding into Real-World Asset (RWA) capabilities, prediction markets, and social betting verticals, building on partnerships like dYdX for BONK.trade and addressing the gap between market cap and its $30 million interest in BONK.fun. CEO Jarrett Boon highlighted Rudy's role in executing the digital pivot with precision.

  • ·Announcement date: April 29, 2026
  • ·Company location: Scottsdale, AZ
  • ·Operates revenue-generating assets in Solana ecosystem
REGIONAL HEALTH PROPERTIES, INC8-Kpositivemateriality 7/10

30-04-2026

On April 26, 2026, Regional Health Properties, Inc. appointed Marlie Davis, CPA, MBA, as Chief Financial Officer effective May 1, 2026; she brings over 20 years of finance, accounting, audit, and real estate investment experience from roles at Hatteras Sky and other firms. Compensation includes an initial annual base salary of $265,000, target bonus of $100,000, 35,000 restricted stock units, and options for 35,000 shares. Separately, Director Christopher Winkle resigned effective May 31, 2026, not due to any disagreement with the company.

  • ·Ms. Davis is age 55, holds an MBA from Utica College and BBA in Accounting from University of Central Florida.
  • ·No arrangements, family relationships, or material interests under Item 404(a) for Ms. Davis.
  • ·Employment is at-will with nine months severance upon termination without cause.
Chemours Co8-Kpositivemateriality 5/10

30-04-2026

Chemours held its annual shareholder meeting on April 24, 2026, where all 11 director nominees were elected with strong support ranging from 95.8% to 99.3% of votes cast. Shareholders also approved the 2026 Equity and Incentive Plan (reserving a maximum of 6,375,275 shares), the advisory say-on-pay vote, and ratification of PricewaterhouseCoopers LLP as independent auditors, with no material opposition noted across proposals.

  • ·Proposal 2 (say-on-pay): 110,058,427 For, 2,527,583 Against, 229,523 Abstain.
  • ·Proposal 3 (Equity Plan): 108,842,885 For, 3,734,567 Against, 238,082 Abstain.
  • ·Proposal 4 (Auditor Ratification): 128,312,790 For, 813,925 Against, 182,394 Abstain (no broker non-votes).
FTAI Aviation Ltd.8-Kpositivemateriality 9/10

30-04-2026

FTAI Aviation Ltd. amended and extended its revolving credit facility, increasing total commitments from $400 million to $2.025 billion and extending the maturity to April 2031. The facility was oversubscribed—a record size for the company—and includes improved pricing terms to reduce borrowing costs and support growth opportunities. Banks led by JPMorgan Chase Bank as Administrative Agent participated, reflecting strong lender confidence.

  • ·Facility led by JPMorgan Chase Bank as Administrative Agent and BNP Paribas, Citibank, MUFG Bank, PNC Bank, Royal Bank of Canada as Syndication Agents.
  • ·Other participants include Barclays, Citizens Bank, Deutsche Bank, Goldman Sachs, Truist Bank as Co-Documentation Agents, plus Capital One, Standard Chartered, and U.S. Bank.
  • ·Announcement made on April 29, 2026; SEC filing dated April 30, 2026.
ACRES Commercial Realty Corp.8-Kmixedmateriality 9/10

30-04-2026

ACRES Commercial Realty Corp. (ACR) announced a definitive all-stock merger agreement to acquire ACRES Capital Corp. (ACC) and its subsidiary ACRES Capital, LLC, internalizing management and expanding assets under management from $2.2B to an anticipated $4.7B, with ~7.5M ACR shares issued (net increase of 6.3M shares after consolidation). The transaction, approved by a Special Committee of independent directors, is expected to align interests (management to own >45% equity), add third-party fee income, and be accretive to earnings available for distribution while supporting dividend stability. However, it remains subject to stockholder approval, customary closing conditions, and carries risks such as failure to close, transition challenges, litigation, or impacts on dividends and retention.

  • ·Merger consideration priced at ACR’s fully diluted book value per share as of December 31, 2025
  • ·Expected closing in third quarter of 2026
  • ·ACR Special Committee advised by BTIG, LLC (financial), Hunton Andrews Kurth LLP (legal), and Meridian Compensation Partners, LLC (compensation)
Lexeo Therapeutics, Inc.8-Kpositivemateriality 6/10

30-04-2026

Lexeo Therapeutics, Inc. appointed Dr. Laura Sepp-Lorenzino, an experienced biotech executive with prior roles at Intellia Therapeutics, Vertex Pharmaceuticals, Alnylam, and Merck, to its board of directors effective April 28, 2026, with her term expiring at the 2028 Annual Meeting of Stockholders. She was also appointed to the Science and Technology Committee. Compensation includes $40,000 annual cash retainer plus an initial stock option for 50,000 shares and future annual grants of 25,000 shares starting in 2027.

  • ·Dr. Sepp-Lorenzino, age 65, holds a Ph.D. in biochemistry from New York University and has extensive experience in genomic medicine, nucleic acid therapies, and oncology.
  • ·No arrangements or understandings with other persons for her appointment; no family relationships with directors or officers.
  • ·Standard indemnification agreement with the Company; no material interests under Item 404(a) of Regulation S-K.
ENTEGRIS INC8-Kpositivemateriality 8/10

30-04-2026

Entegris, Inc. (NASDAQ: ENTG) announced the appointment of Sukhi Nagesh as Chief Financial Officer effective May 18, 2026, bringing nearly 30 years of finance, investor relations, and corporate development experience from Nielsen, GlobalFoundries, Marvell Technology, Applied Materials, Brooks Automation, and Asyst Technologies. The appointment follows a rigorous search, with CEO Dave Reeder praising Nagesh's industry expertise. Mike Sauer, Interim CFO since March 1, 2026, transitions back to VP, Chief Accounting Officer.

  • ·Entegris has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan.
  • ·Entegris is ISO 9001 certified.
Fermi Inc.8-Kneutralmateriality 7/10

30-04-2026

Fermi Inc., a Real Estate Investment Trust, appointed Robert L. Masson as Interim Chief Financial Officer and principal financial officer effective April 29, 2026, until a permanent successor is named. Mr. Masson, age 55, has over 20 years of finance executive experience in aerospace, defense, and industrial sectors, including prior CFO roles at Noble Supply and Logistics, Latham Group, Inc., Hypertherm, Inc., and others. No compensation arrangements have been approved, and there are no related understandings, family relationships, or material conflicts disclosed.

  • ·Mr. Masson served as CFO of Noble Supply and Logistics from 2023-2025, CFO of Latham Group from 2022-2023, EVP and CFO of Hypertherm from 2018-2022, VP of Finance at Flowserve from 2016-2018, and various finance roles at Raytheon Technologies from 2003-2016.
  • ·Mr. Masson began career as Lieutenant and Naval Aviator in U.S. Navy (1992-2001).
  • ·Holds Bachelor of Science in Economics from United States Naval Academy and MBA from Harvard Business School.
  • ·Company is an emerging growth company and lists common stock ($0.001 par value) on Nasdaq (FRMI) and London Stock Exchange.
MOVING iMAGE TECHNOLOGIES INC.8-Kpositivemateriality 8/10

30-04-2026

Moving iMage Technologies, Inc. appointed Bart Bedard as Chief Financial Officer effective April 27, 2026, reporting to Francois Godfrey, President & COO, with responsibilities including financial operations, SEC compliance, and process automation. Compensation includes a $200,000 annual base salary, $10,000 signing bonus, 75,000 stock options (25% vesting immediately, remainder over three years), and benefits like 401(k), healthcare, and four weeks vacation. Transition support from Bill Greene is planned through Q3 close (March 31), Q1 10-Q (mid-May), and 10-K (October 2026).

  • ·Stock options include immediate 25% vesting and remaining 75% in equal annual installments over three years; full vesting upon change of control.
  • ·Signing bonus subject to pro-rata repayment if voluntary resignation within 12 months.
  • ·Transition: Bill Greene active through Q3 close (March 31), part-time through Q1 10-Q (mid-May), light advisory through 10-K (October 2026).
Warner Bros. Discovery, Inc.8-Kneutralmateriality 7/10

30-04-2026

Warner Bros. Discovery, Inc. entered into a new employment agreement with CFO Gunnar Wiedenfels, effective July 11, 2026, extending his term until April 28, 2028, with a base salary of $2,500,000, target annual bonus of 175% of base, annual equity awards targeting $10,000,000, and a one-time $2,000,000 RSU award on August 17, 2026. The agreement includes standard severance provisions up to 24 months and restrictive covenants, consistent with practices for executive renewals and permitted under the pending merger with Paramount Skydance Corporation. No changes to duties or indications of departure.

  • ·Severance benefits include up to 24 months base salary continuation, target bonuses, health benefits, and repatriation to Germany upon termination without Cause or for Good Reason.
  • ·Noncompetition covenant: 12 months post-employment; nonsolicitation: 18 months post-employment.
  • ·Equity awards accelerate fully upon Change in Control termination within 12 months.
MARA Holdings, Inc.8-Kpositivemateriality 9/10

30-04-2026

MARA Holdings, Inc. entered a definitive agreement to acquire Long Ridge Energy & Power LLC from FTAI Infrastructure for $1.5 billion, including assumption of at least $785 million debt, adding a 505 MW combined-cycle gas power plant and over 1,600 acres supporting >1 GW total potential capacity. The deal increases MARA's owned and operated capacity by 65% to 2.2 GW and adds ~$144 million annualized Adjusted EBITDA at < $15/MWh all-in operating costs. No declines or flat metrics reported; transaction expected to close H2 2026 subject to approvals.

  • ·Power plant currently authorized to sell 485 MW, expected to increase to 505 MW nameplate in H2 2026
  • ·Over 1,600 contiguous acres, including 125 acres of industrially permitted land
  • ·100 MMcfd vertically integrated fuel supply
  • ·Initial AI/Critical IT construction to begin 1H 2027, targeted ready mid-2028
  • ·Conference call April 30, 2026 at 8:00 a.m. ET
  • ·Closing subject to Hart-Scott-Rodino Act, FERC approval, and customary conditions
CCC Intelligent Solutions Holdings Inc.8-Kmixedmateriality 8/10

30-04-2026

CCC Intelligent Solutions Holdings Inc. announced that Brian Herb, Executive Vice President and Chief Financial & Administrative Officer, will depart effective May 25, 2026, with Rodney Christo, Senior Vice President of Finance & Chief Accounting Officer with over 30 years at CCC, assuming the interim CFO role for continuity. Q1 2026 financial results showed revenue of $281.3 million, up 12% YoY from Q1 2025, and adjusted EBITDA of $120.2 million, up 21% YoY from $99.1 million. No declines or flat metrics were reported, supporting ongoing growth amid the leadership transition.

  • ·Brian Herb will continue to support the company as an advisor post-departure.
  • ·Rodney Christo has served CCC in positions of increasing responsibility for more than 30 years.
FTAI Infrastructure Inc.8-Kpositivemateriality 10/10

30-04-2026

FTAI Infrastructure Inc. (FIP) entered into a definitive agreement to sell Long Ridge Energy & Power LLC and related assets to a subsidiary of MARA Holdings, Inc. for approximately $1.52 billion, expected to close in Q3 2026 subject to regulatory approvals. The transaction will eliminate $1.16 billion of asset-level debt and enable repayment of approximately $300 million of corporate debt, supporting deleveraging and reinvestment in growth opportunities like freight rail and terminals. No operating performance declines or flat metrics were reported.

  • ·Long Ridge headquartered in Pittsburgh, Pennsylvania, with working interests in natural gas production wells
  • ·Financial advisors: Jefferies and Lazard; legal counsel: Skadden, Arps, Slate, Meagher & Flom LLP
  • ·First quarter earnings call on May 8 to provide additional transaction details
  • ·Transaction subject to customary closing conditions including regulatory approvals
BORGWARNER INC8-Kpositivemateriality 4/10

30-04-2026

BorgWarner Inc. (NYSE: BWA) declared a quarterly cash dividend of $0.17 per share of common stock on April 29, 2026, payable on June 15, 2026, to stockholders of record on June 1, 2026. The announcement was included as Exhibit 99.1 in the company's 8-K filing dated April 30, 2026. No changes in dividend amount or other financial metrics were compared to prior periods in the release.

  • ·Contact for inquiries: Patrick Nolan at 248.754.0884
NEUROONE MEDICAL TECHNOLOGIES Corp8-Kneutralmateriality 7/10

30-04-2026

NeuroOne Medical Technologies Corporation announced that Ronald McClurg, its Chief Financial Officer, will retire from the officer role effective June 30, 2026, and transition to Senior Advisor until his full separation on December 31, 2026, under a Transition and Release Agreement. Christopher Volker, the current Chief Operating Officer, will succeed as Chief Financial Officer effective July 1, 2026, with his base salary increased to $350,000. The changes ensure a smooth transition with Volker's extensive medtech experience from Abbott, Cardiovascular Systems, Inc., and St. Jude Medical.

  • ·Transition and Release Agreement dated April 28, 2026, provides McClurg continued salary and benefits through December 31, 2026, eligibility for FY2026 performance bonus if employed through September 30, 2026, and post-separation consulting services counting as 'Continuous Services' for equity vesting.
  • ·McClurg resigns as officer effective July 1, 2026, when his role changes to Special Advisor.
  • ·Volker's other compensatory terms remain unchanged; he holds CFA designation, BA from St. John’s University, and MBA from Wharton.
Brand Engagement Network Inc.8-Kpositivemateriality 9/10

30-04-2026

Brand Engagement Network, Inc. (NASDAQ: BNAI) signed a definitive agreement to acquire Cataneo GmbH for $19.5 million in a debt-free transaction funded by $8 million in secured capital commitments and $10.5 million in BEN common stock at $39.59 per share. The acquisition integrates Cataneo’s MYDAS platform, which manages €6 billion+ in annual advertising inventory across 1,000+ media brands and 200+ channels, with BEN’s patented AI technology to enable 1:1 engagement. The deal is expected to close on June 30, 2026, subject to customary conditions, with no current performance declines noted but forward-looking risks including financing and regulatory approvals.

  • ·Cataneo headquartered in Munich, Germany, with over 20 years of experience across four continents.
  • ·Transaction eliminates reliance on discounted or dilutive capital.
  • ·Leadership continuity with Christian Unterseer joining BEN’s Board upon closing.
  • ·Expected closing date: June 30, 2026, subject to customary conditions and risks including financing, regulatory approvals, and potential termination.
BayFirst Financial Corp.8-Kmixedmateriality 9/10

30-04-2026

BayFirst Financial Corp. raised $80 million through a PIPE offering of convertible preferred stock, convertible to approximately 22.9 million common shares at $3.50 per share, and appointed Alfred Rogers as Bank CEO/President replacing retiring Tom Zernick, while naming Kenneth R. Lehman to the boards. However, Q1 2026 results showed a widened net loss of $5.7 million ($1.48 per share) versus $2.5 million in Q4 2025 and $0.3 million in Q1 2025, with loans down 3.5% QoQ to $930.4 million and 14.2% YoY, deposits down 8.3% QoQ to $1.09 billion, and NIM contracting 16 bps QoQ to 3.42%. The capital raise is expected to strengthen proforma capital ratios, including Tier 1 leverage to 10.02%, amid plans to resume preferred dividends and develop an Asset Resolution Plan.

  • ·Noninterest income $0.9M in Q1 2026 vs negative $0.1M in Q4 2025 (increase) but down from $8.8M in Q1 2025 due to lower gains on govt guaranteed loan sales.
  • ·Noninterest expense $14.9M in Q1 2026, up from $11.9M in Q4 2025 but down from $15.8M in Q1 2025.
  • ·Allowance for credit losses to loans 2.35% at March 31, 2026 (down from 2.42% Dec 31, 2025 but up from 1.61% March 31, 2025).
  • ·Bank not well-capitalized at March 31, 2026 but proforma CET1 13.13% and total capital 14.40% post-capital contribution.
  • ·Special shareholder meeting July 14, 2026 to approve share increase for PIPE conversion; record date May 12, 2026.
Health Catalyst, Inc.8-Kpositivemateriality 7/10

30-04-2026

Health Catalyst, Inc. (Nasdaq: HCAT) appointed Steve Nelson, Executive Vice President and President of Aetna (a CVS Health company), to its Board of Directors effective May 1, 2026, continuing leadership enhancements with Ben Albert as CEO and Justin Spencer as Chairman earlier in the year. Nelson brings extensive experience from roles at Aetna, ChenMed, Duly Health and Care, and UnitedHealthcare, aimed at accelerating the company's transformation in healthcare intelligence. The company is backed by $2.8 billion in documented outcomes.

  • ·Filing references risk factors in 10-Q for quarter ended September 30, 2025 (filed November 10, 2025) and 10-K for year ended December 31, 2024 (filed February 26, 2025, amended April 30, 2025)
GrabAGun Digital Holdings Inc.8-Kneutralmateriality 6/10

30-04-2026

On April 28, 2026, the Board of Directors of GrabAGun Digital Holdings Inc. nominated Marc Nemati, Matt Vittitow, Chris Cox, Andrew J. Keegan, Collins Idehen Jr., Blake Masters, Kelly Reisdorf, and Donald J. Trump Jr. for reelection at the 2026 annual meeting of shareholders, to serve until the 2027 annual meeting. Director Dusty Wunderlich, whose term expires at the upcoming meeting, will not stand for reelection by mutual agreement with the Nomination and Governance Committee. The Board expressed gratitude for Mr. Wunderlich's service.

  • ·Filing date: April 30, 2026
  • ·Event date: April 28, 2026
  • ·Trading symbols: PEW (common stock, NYSE), PEWW (redeemable warrants, NYSE)
  • ·Company is an emerging growth company
  • ·Incorporated in Texas, EIN: 33-4289144, CIK: 0002051380
Eos Energy Enterprises, Inc.8-Kpositivemateriality 8/10

30-04-2026

Eos Energy Enterprises, Inc. announced the appointment of Alessandro Lagi as Chief Financial Officer effective June 8, 2026, replacing Nathan Kroeker who transitions from interim CFO to Chief Commercial Officer. Mr. Lagi, with prior roles at Johnson Controls and Baker Hughes, will receive a $470,000 base salary, $2,000,000 initial RSU grant, and $1,000,000 annual LTIP target. The move strengthens financial leadership with no reported disruptions.

  • ·Employment Agreement dated April 28, 2026.
  • ·Target annual bonus opportunity: 100% of base salary.
  • ·Severance includes 12 months salary continuation, pro-rata bonus, and 12-month equity vesting acceleration.
  • ·Post-termination restrictions: 12-month non-compete and non-solicit, perpetual non-disparagement.
  • ·No arrangements, family relationships, or material interests under Item 404(a).
Innventure, Inc.8-Kpositivemateriality 7/10

30-04-2026

Innventure, Inc. appointed John Hewitt as an independent Class I director effective immediately to fill the vacancy from Daniel Hennessy's resignation on April 29, 2026, and nominated Catriona Fallon as an independent Class II director for election at the June 17, 2026 Annual Meeting of Stockholders. These changes, following shareholder engagement including with Ascent Capital Partners, aim to enhance board expertise in operations, data center infrastructure, and financial governance as the company scales its industrial growth model. CEO Bill Haskell emphasized the strategic fit for oversight in a multi-entity operating structure.

  • ·Daniel Hennessy resignation: April 29, 2026
  • ·John Hewitt term: expires at 2028 Annual Meeting
  • ·Catriona Fallon proposed term: expires at 2029 Annual Meeting
  • ·Definitive Proxy Statement filed: April 30, 2026
  • ·Annual Meeting date: June 17, 2026
GOLDEN ENTERTAINMENT, INC.8-Kmixedmateriality 10/10

30-04-2026

On April 30, 2026, New Royal HoldCo I Inc. (successor to Golden Entertainment, Inc.) consummated the Master Transaction Agreement by selling 100% of New OpCo equity to Argento, LLC, distributing a $2.75 per share dividend to shareholders, and merging into a VICI Properties Inc. subsidiary, with each New HoldCo share converting to 0.902 VICI shares. The First Lien Credit Agreement was fully terminated and obligations satisfied. Trading on Nasdaq was suspended, delisting via Form 25 initiated, and all directors and certain officers resigned or ceased roles, with the company planning to file Form 15 to terminate SEC reporting obligations.

  • ·Equity awards (Company Options, RSUs, PSUs, Restricted Stock) accelerated and vested at target performance, settled net of taxes prior to F-Reorganization.
  • ·Nasdaq notified of transaction completion; requested trading suspension, Form 25 for delisting, and plans to file Form 15 for termination of registration under Sections 12(g), 13, and 15(d).
  • ·Blake L. Sartini employment terminated post-Merger, receiving severance under employment agreement.
GEN Restaurant Group, Inc.8-Kneutralmateriality 5/10

30-04-2026

Analysis unavailable

Clearfield, Inc.8-Kneutralmateriality 4/10

30-04-2026

Clearfield, Inc. entered into Amendment No. 3 to its Loan Agreement with Old National Bank on April 25, 2026, extending the maturity of the line of credit from April 25, 2026, to July 24, 2026. The amendment incorporates updated interest and payment provisions previously in the promissory note, adds events constituting default, and includes a jury trial waiver. All other material terms of the original Loan Agreement dated April 27, 2022, remain unchanged.

  • ·Amendment filed as Exhibit 10.1
  • ·Original Loan Agreement dated April 27, 2022
CAMDEN PROPERTY TRUST8-Kneutralmateriality 8/10

30-04-2026

Camden Property Trust entered into new 'at the market' sales agreements on April 28, 2026, with managers including Deutsche Bank Securities Inc., BMO Capital Markets Corp., Regions Securities LLC, Scotia Capital (USA) Inc., and Truist Securities, Inc., for the offer and sale of up to $500,000,000 in common shares, renewing the program expiring May 12, 2026. The agreements allow sales of primary shares and forward hedge shares, with no obligation to sell any shares. Net proceeds, if any, will be used for general corporate purposes including reducing borrowings under its $1.2 billion unsecured revolving credit facility.

  • ·Existing ATM agreements terminated on April 28, 2026.
  • ·Sales of shares to be made via ordinary brokers’ transactions at market or negotiated prices.
  • ·Forward sale agreements may be physically, cash, or net share settled.
  • ·Registration statement on Form S-3 and prospectus supplement filed April 28, 2026.
  • ·Agreements filed as Exhibits 1.1 through 1.5.
KIRBY CORP8-Kmixedmateriality 9/10

30-04-2026

Kirby Corporation reported Q1 2026 net earnings of $81.2 million ($1.50 per share, +13% YoY) and revenues of $844.1 million (+7.5% YoY), driven by 23% YoY revenue growth in coastal marine and 45% in power generation, while raising full-year EPS growth guidance to 5%-15%. However, inland marine revenues were flat YoY amid weather disruptions, distribution and services operating margin declined to 6.7% from 7.3%, and oil & gas revenues fell 25% YoY with operating income down 53%. The company acquired 23 barges and three boats for $95.8 million and repurchased $52.7 million in shares.

  • ·Amended credit agreement on March 26, 2026: extended maturity to 2031, revolving facility to $750M, eliminated term loan.
  • ·Debt-to-capitalization ratio 22.3% as of March 31, 2026.
  • ·2026 full-year guidance: operating cash flow $575M-$675M, capex $220M-$260M; inland revenues low-to-mid single-digit growth, coastal mid-single-digit growth, distribution & services flat to slightly higher.
Diameter Credit Co8-Kneutralmateriality 8/10

30-04-2026

Diameter Capital PC CLO 2 LLC entered into a Purchase Agreement dated April 24, 2026, with Citigroup Global Markets Inc. to issue and sell Notes (Securities) and incur Class A-1 Loans (collectively, Debt) on a private placement basis under Section 4(a)(2) of the Securities Act, with closing on the same date. The Issuer, managed by Diameter Credit Company, intends to invest proceeds in a portfolio of U.S. dollar-denominated senior secured loans. No specific principal amounts or pricing details are provided in the agreement excerpt, and there are no period-over-period financial comparisons or negative performance indicators.

  • ·Preliminary Offering Circular dated March 20, 2026; Second Preliminary Offering Circular dated March 26, 2026; Final Offering Circular dated April 22, 2026.
  • ·Engagement Letter dated March 26, 2026, between Citigroup and the Collateral Manager.
  • ·Transaction Documents include Indenture, Credit Agreement, Collateral Management Agreement, and others.
  • ·Issuer organized as Delaware LLC; Debt rated by S&P.
Greenpro Capital Corp.8-Kpositivemateriality 7/10

30-04-2026

Greenpro Capital Corp. entered into a subscription agreement with its CEO, President, and Director, Mr. Lee Chong Kuang, for the private placement of 107,310 shares of common stock at $2.3297 per share, generating aggregate gross proceeds of $250,000. The offering closed on April 28, 2026, increasing total outstanding shares to 18,033,123, with Mr. Lee now holding 1,846,344 shares (10.24%) directly and 2,012,259 shares (11.16%) aggregate with his spouse Ms. Yap Pei Ling. Proceeds are intended for operating capital, with the issuance relying on exemptions under Section 4(a)(2), Regulation D, and/or Regulation S of the Securities Act.

  • ·Issuance exempted under Section 4(a)(2) of the Securities Act, Regulation D, and/or Regulation S; Purchaser represented as accredited investor and/or non-U.S. person.
  • ·No underwriters involved in the offering.
MATRIX SERVICE CO8-Kneutralmateriality 8/10

30-04-2026

Matrix Service Company announced the departures of CFO Kevin S. Cavanah and Chief Administrative Officer Nancy E. Austin as part of organizational changes ahead of Shawn P. Payne assuming the CEO role on July 1, 2026. Cavanah will continue through the filing of the FY2026 10-K for transition and receive a $771,000 lump sum severance payment plus equity vesting benefits upon separation. Austin will step down effective May 7, 2026, receiving a $608,345 lump sum severance payment, 18 months of COBRA coverage, and vesting of 20,368 restricted stock units; neither departure stems from disagreements.

  • ·Cavanah to serve through earliest of one week post FY2026 10-K filing or termination without Cause.
  • ·Both receive 18 months Company-paid COBRA coverage and performance units eligible for vesting based on actual performance.
  • ·Cavanah Agreement signed April 29, 2026; Austin Agreement expected.
  • ·New CFO to be based in Houston with Payne; CAO role eliminated, duties redistributed.
Rivian Automotive, Inc. / DE8-Kneutralmateriality 9/10

30-04-2026

Rivian Automotive, Inc. (Sponsor/Guarantor) and its subsidiary Rivian New Horizon, LLC (Borrower) entered into an Amended and Restated Loan Arrangement and Reimbursement and Sponsor Support Agreement with the U.S. Department of Energy on April 30, 2026, amending the initial agreement dated January 16, 2025. The agreement facilitates a multi-draw term loan facility under the ATVM Program through the Federal Financing Bank, with DOE issuing Principal Instruments for note purchases, subject to extensive conditions precedent, covenants, representations, and sponsor support including equity commitments and guarantees. No specific loan amounts or financial metrics are disclosed in the filing.

  • ·Application submitted October 23, 2022; deemed substantially complete March 3, 2023.
  • ·Conditional Commitment Letter dated November 25, 2024.
RLJ Lodging Trust8-Kpositivemateriality 6/10

30-04-2026

On April 24, 2026, RLJ Lodging Trust held its Annual Meeting where shareholders elected nine trustees (Robert L. Johnson, Leslie D. Hale, Evan Bayh, Arthur R. Collins, Nathaniel A. Davis, Patricia L. Gibson, Robert M. La Forgia, Robert J. McCarthy, and Robin Zeigler), ratified PricewaterhouseCoopers LLP as independent auditors for FY ending December 31, 2026, approved named executive officer compensation on an advisory basis, and approved the 2026 Equity Incentive Plan providing for up to 4,763,000 common shares. All proposals passed with strong shareholder support, including over 106 million votes for each trustee nominee and 109,275,582 votes for the 2026 Plan. The 2026 Plan, adopted by the Board on March 13, 2026, replaces the 2021 Plan and terminates on the tenth anniversary of its April 24, 2026 effective date.

  • ·Trustee election votes: Robert L. Johnson (107,517,178 For, 5,633,406 Against); Leslie D. Hale (112,021,180 For, 1,131,360 Against); all others over 106M For.
  • ·Auditor ratification: 112,401,134 For, 5,980,919 Against, 33,353 Abstentions.
  • ·Exec comp advisory: 99,057,306 For, 14,041,217 Against, 63,987 Abstentions.
  • ·2026 Plan approval: 109,275,582 For, 3,835,789 Against, 51,139 Abstentions.
  • ·Proxy Statement filed March 23, 2026; 2026 Plan to be filed in 10-Q for quarter ending June 30, 2026.
OLIN Corp8-Kneutralmateriality 4/10

30-04-2026

Olin Corporation amended its bylaws effective April 30, 2026, with detailed provisions on shareholder meetings, including place, annual and special meeting rules, notice requirements (10-60 days), quorum (majority of votes), and voting procedures. The amendments impose strict advance notice requirements for shareholder-proposed business, such as 120-150 calendar days before the annual meeting anniversary for timely notices, along with extensive disclosure obligations regarding share ownership, derivatives, and material interests. No financial impacts or performance metrics are disclosed.

  • ·Shareholder notice for annual meetings: not later than 120 calendar days or earlier than 150 calendar days before anniversary of prior annual meeting.
  • ·Special meetings callable by Board, Chair, President, Secretary, or holders of majority of voting shares.
  • ·Proxy solicitation by shareholders must use non-white proxy cards.
COGNEX CORP8-Kpositivemateriality 6/10

30-04-2026

On April 29, 2026, Cognex Corporation's Board determined that Joerg Kuechen will no longer be deemed an executive officer under SEC rules but will continue as Head of Mergers and Acquisitions. At the 2026 Annual Meeting of Shareholders on the same date, with 153,890,280 shares represented out of 167,013,856 outstanding, shareholders elected Matthew Moschner, Angelos Papadimitriou, and Christopher Donato as directors to serve until 2029, approved an amendment to the 2023 Stock Option and Incentive Plan, ratified KPMG LLP as independent auditors for fiscal 2026, and approved named executive officer compensation on an advisory basis, all as recommended by the Board.

  • ·Director election votes - Matthew Moschner: For 136,554,604; Against 2,824,917; Abstained 107,328; Broker Non-Votes 14,403,431
  • ·Director election votes - Angelos Papadimitriou: For 121,262,948; Against 18,115,308; Abstained 108,593; Broker Non-Votes 14,403,431
  • ·Director election votes - Christopher Donato: For 134,157,408; Against 5,216,762; Abstained 112,679; Broker Non-Votes 14,403,431
  • ·Stock plan amendment: For 135,582,856; Against 3,763,664; Abstained 140,329; Broker Non-Votes 14,403,431
  • ·Auditor ratification: For 153,641,083; Against 83,521; Abstained 165,676
  • ·Say-on-pay: For 109,615,176; Against 29,685,048; Abstained 186,625; Broker Non-Votes 14,403,431
Claritev Corp8-Kpositivemateriality 6/10

30-04-2026

At its 2026 Annual Meeting of Stockholders on April 29, 2026, Claritev Corporation's stockholders elected four Class III directors (Anthony Colaluca, Jr., Michael S. Klein, Allen R. Thorpe, and Dale A. White) with strong support exceeding 90% of votes cast for each. Stockholders also ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026 (over 99% approval), approved an advisory vote on named executive officer compensation (~85% approval), and approved an amendment to the 2020 Omnibus Incentive Plan adding 2,375,000 shares to the reserve. All proposals passed with significant majorities and no notable opposition.

  • ·Proposal 2 (auditor ratification): 6,243 votes AGAINST, 476 ABSTAIN.
  • ·Proposal 3 (exec comp): 1,542,188 votes AGAINST, 14,726 ABSTAIN.
  • ·Proposal 4 (plan amendment): 701,502 votes AGAINST, 8,339 ABSTAIN.
  • ·Amendment filed as Exhibit 10.1.
ProPetro Holding Corp.8-Kmixedmateriality 9/10

30-04-2026

ProPetro reported Q1 2026 total revenue of $271 million, down 7% QoQ from $290 million, with net loss of $4 million ($0.03 per diluted share) versus $1 million net income prior quarter, and Adjusted EBITDA declining 29% to $36 million (13% of revenue) from $51 million. Despite weather-related disruptions impacting completions utilization, the company secured a strategic framework agreement with Caterpillar Inc. for up to 2.1 gigawatts additional PROPWR power capacity over five years, positioning for 2.6 gigawatts total by year-end 2031, amid advanced negotiations for 100 megawatts oil/gas microgrids and several hundred megawatts data center opportunities. FY2026 capex guidance raised to $540-610 million, reflecting PROPWR growth, while Q2 expects 12 active frac fleets signaling completions recovery.

  • ·Capital expenditures incurred split: $14M completions maintenance, $71M PROPWR orders in Q1 2026.
  • ·FY2026 capex guidance: $140-160M completions (incl. $40-50M FORCE lease buyouts), $400-450M PROPWR.
  • ·PROPWR: ~550 MW previously ordered, ~240 MW currently committed, advanced negotiations for ~100 MW oil/gas microgrids, several hundred MW data center opportunities.
  • ·PROPWR positioned for ~2.1 GW additional capacity over 5 years via Caterpillar agreement, total ~2.6 GW by YE 2031.
Evofem Biosciences, Inc.8-Kpositivemateriality 8/10

30-04-2026

Evofem Biosciences, Inc. entered into an exclusive Distribution Agreement with Clovis Davis Pharmaceuticals, LLC, for the commercialization of SOLOSEC® (secnidazole 2g oral granules) in sub-Saharan Africa, an FDA-approved single-dose treatment for bacterial vaginosis (BV) and trichomoniasis. The agreement highlights significant market potential, with BV affecting an estimated 25% of women in the region and 10.9 million eligible women in Ethiopia alone from a population of 43.8 million aged 12+. Clovis Davis will handle distribution, promotion, and sales, while developing women's health initiatives including the OSOM® BVBlue® test in Ethiopia and Uganda.

  • ·Announcement date: April 27, 2026
  • ·Filing date: April 30, 2026
  • ·Approximately one third of global new trichomoniasis infections occur in the WHO African Region
  • ·Local regulatory approvals based on Evofem’s U.S. FDA dossier
TechTarget, Inc.8-Kneutralmateriality 6/10

30-04-2026

On April 24, 2026, the Compensation Committee of TechTarget, Inc.'s Board approved the Executive Incentive Growth Acceleration Plan (GAP) for the 2026-2028 period and the 2026 Executive Short-Term Incentive Plan (STIP). The GAP offers cash bonuses to covered executives based on annual CAGR revenue and operating profit margin targets, using synthetic shares valued 60% on TechTarget stock and 40% on Informa PLC stock, with share price floors at 50% and ceilings at 200% of grant date prices. The STIP ties bonuses 80% to revenue targets and 20% to operating profit targets, with payouts capped at 300% for non-CEO revenue and 150% for profit (CEO capped at 150% per metric).

  • ·GAP bonuses banked annually for 2026-2028, with opportunity to earn back unbanked portions from first two years if maximum targets achieved later.
  • ·STIP incremental payouts: each 1% above 100% target yields 10% incremental payout for non-CEO.
  • ·No specific performance targets or base salary percentages disclosed.
LEXICON PHARMACEUTICALS, INC.8-Kneutralmateriality 6/10

30-04-2026

Lexicon Pharmaceuticals, Inc. adopted and filed its Seventh Amended and Restated Certificate of Incorporation, approved by the Board of Directors and a majority of stockholders, amending the prior certificate filed on May 10, 2024. The amendment authorizes 905,000,000 shares of capital stock, consisting of 900,000,000 shares of common stock (par value $0.001 per share) and 5,000,000 shares of preferred stock (par value $0.01 per share), with standard provisions for issuance, voting, dividends, and liquidation preferences. The changes became effective upon filing with the Delaware Secretary of State.

  • ·Registered office: 251 Little Falls Drive, Wilmington, County of New Castle, DE 19808.
  • ·Originally incorporated as Lexicon Genetics Incorporated on July 7, 1995.
  • ·Board of Directors fixed between 3 and 13 members, classified into three classes.
  • ·No preemptive rights for stockholders.
  • ·References Stockholders’ Agreement dated June 17, 2007 with Invus, L.P.
TIPTREE INC.8-Kmixedmateriality 9/10

30-04-2026

Tiptree Inc. reported Q1 2026 diluted EPS of $0.34, up from $0.13 YoY, driven by net income from discontinued operations of $21.4 million versus $15.3 million, while continuing operations showed a net loss of $7.1 million (improved from $9.7 million) with zero revenues compared to $0.4 million. The company repurchased shares for $5.0 million at an average $16.13 per share and declared a $0.06 per share dividend; updates on pending sales include Fortegra for $1.65 billion ($1.12 billion proceeds) and Reliance First Capital for $50 million, projecting pro-forma book value of $912 million ($23.80 per diluted share). Book value per share rose to $13.42 from $12.63 YoY.

  • ·Total stockholders’ equity $750.5 million as of March 31, 2026, slightly down from $752.4 million at Dec 31, 2025.
  • ·Assets held for sale increased to $6.91 billion from $6.77 billion QoQ.
  • ·Anticipated closing for both Fortegra and Reliance transactions remains mid-2026, pending regulatory approvals.
Level 3 Parent, LLC8-Kneutralmateriality 7/10

30-04-2026

Level 3 Parent, LLC, Level 3 Financing, Inc., and Lumen Technologies, Inc. entered into a First Supplemental Indenture dated April 30, 2026, supplementing the original Indenture dated June 30, 2025, for 6.875% First Lien Notes due 2033. Lumen Technologies, Inc. (Parent Guarantor) provides an unconditional senior unsecured guarantee for the Issuer's obligations under the notes, jointly and severally with existing guarantors. The guarantee is automatically releasable under specified conditions, including cessation of subsidiary status or Issuer notice, with no financial amounts or performance metrics disclosed.

  • ·Original Indenture dated June 30, 2025.
  • ·Guarantee excludes Articles 7 and 9 of the Indenture (except specific section).
  • ·Governing law: State of New York.
MARCUS CORP8-Kpositivemateriality 6/10

30-04-2026

Marcus Corporation (NYSE: MCS) announced that Mark A. Gramz, president of Marcus Theatres, will retire on March 31, 2026, after 55 years of service, starting from a ticket taker role. A national search for his successor is underway, with Gramz to serve as an advisor post-retirement to ensure a smooth transition. CEO Gregory S. Marcus commended Gramz's leadership and contributions to the moviegoing experience.

  • ·Marcus Theatres is the fourth largest theatre circuit in the U.S.
  • ·Gramz promoted to president of Marcus Theatres in 2022; joined corporate team in 1990.
  • ·Gramz received Salah M. Hassanein Humanitarian Award from ShowEast in October 2024.
  • ·Announcement dated October 30, 2025.
FS Credit Real Estate Income Trust, Inc.8-Kneutralmateriality 6/10

30-04-2026

FS Credit Real Estate Income Trust, Inc., as Guarantor, and its subsidiary FS CREIT FINANCE BMO-1 LLC, as Seller, entered into Amendment No. 5 to the Master Repurchase Agreement with Bank of Montreal, acting through its Chicago Branch as Buyer, effective April 29, 2026. The amendment modifies certain terms of the original agreement dated March 3, 2023, incorporates the Pricing Side Letter, and includes a ratification and reaffirmation of the existing Guaranty. No quantitative financial changes, performance metrics, or material impacts such as increases or decreases in facility sizes are disclosed.

  • ·Original Master Repurchase Agreement dated March 3, 2023.
  • ·Amendment deletes stricken text and adds double-underlined text as per Exhibit A.
  • ·Guarantor ratifies the Limited Guaranty dated March 3, 2023.
Match Group, Inc.8-Kneutralmateriality 5/10

30-04-2026

Match Group, Inc. appointed Raina Moskowitz to its Board of Directors effective at the 2026 annual meeting of stockholders, filling the vacancy from Pamela S. Seymon's resignation effective the same date, with Ms. Moskowitz's term expiring at the 2027 annual meeting. The Board has not yet determined her committee assignments. As previously announced, Manuel Bronstein will stand for election to the Board at the 2026 annual meeting.

  • ·No arrangement or understanding between Ms. Moskowitz and any other person for her selection as director.
  • ·No related party transactions involving Ms. Moskowitz reportable under Item 404(a) of Regulation S-K.
  • ·Ms. Moskowitz will participate in the Company's non-employee director compensation program as described in Exhibit 10.26 to the Form 10-K filed February 26, 2026.
Armour Residential REIT, Inc.8-Kpositivemateriality 6/10

30-04-2026

ARMOUR Residential REIT, Inc. held its 2026 Annual Meeting on April 30, 2026, where stockholders elected all eight director nominees with strong majorities (e.g., Scott J. Ulm received 50,758,487 For votes), ratified Deloitte & Touche LLP as independent auditors for fiscal year 2026 (80,520,125 For), approved 2025 executive compensation on an advisory basis (48,910,162 For), selected annual frequency for future advisory votes (50,596,296 for one year), and approved the Fourth Amended and Restated 2009 Stock Incentive Plan increasing authorized Common Stock shares by 1,000,000 (49,418,684 For). Voting turnout represented 83,300,043 shares or 67.85% of 122,767,466 outstanding shares. All proposals passed decisively with no significant opposition.

  • ·Proxy statement filed March 19, 2026; record date March 6, 2026.
  • ·Fourth A&R Plan effective April 30, 2026, terminates April 29, 2036.
  • ·Plan adjusts per-share limits from 750,000 to 150,000 post 1-for-5 reverse stock split in September 2023; adds clawback provision.
PHIBRO ANIMAL HEALTH CORP8-Kpositivemateriality 8/10

30-04-2026

Phibro Animal Health Corporation entered into Amendment No. 1 to its July 3, 2024 Credit Agreement on April 28, 2026, increasing the aggregate Revolving Credit Commitments by $125,000,000 through Incremental Revolving Commitments provided by Incremental Revolving Lenders. Rabobank, as Administrative Agent and Collateral Agent, facilitated the amendment, which includes an upfront fee of 0.15% for participating lenders and becomes effective upon satisfaction of customary conditions, including pro forma compliance with financial covenants. No declines or flat metrics reported; the increase enhances liquidity without identified drawbacks.

  • ·Amendment executed pursuant to Section 2.14 of the Credit Agreement.
  • ·Conditions to effectiveness include executed counterparts, payment of fees, organizational documents, representations and warranties, no Default, legal opinions, KYC documentation, and Responsible Officer certificate.
  • ·Post-closing: Delivery of opinions or confirmations on Mortgaged Properties within 90 days.
SM Energy Co8-Kpositivemateriality 9/10

30-04-2026

SM Energy Company closed the sale of certain South Texas assets for a cash purchase price of $950 million, generating net cash proceeds of approximately $900 million after adjustments and costs, advancing momentum toward its $1.0 billion-plus divestiture target. Concurrently, the company announced full redemption of its $819 million aggregate principal amount of 2026 Senior Notes ($419 million 6.75% due September 15, 2026, and $400 million 5.0% due October 15, 2026). The credit facility's borrowing base and lender commitments were reaffirmed at $5.0 billion and $2.5 billion, respectively, supporting balance sheet strengthening.

  • ·6.75% Senior Notes redemption planned for June 1, 2026
  • ·5.0% Senior Notes redemption planned for May 11, 2026
  • ·Merger with Civitas closed on January 30, 2026
  • ·Semi-annual borrowing base redetermination completed subsequent to March 31, 2026
  • ·Final purchase price for South Texas Divestiture subject to customary post-closing adjustments
NexPoint Real Estate Finance, Inc.8-Kpositivemateriality 9/10

30-04-2026

NexPoint Real Estate Finance, Inc. entered into a senior secured term loan agreement with Mizuho Capital Markets LLC on April 29, 2026, to fund the repayment of its 5.75% Senior Notes due May 1, 2026. The facility features an Applicable Margin of 4.00% per annum and an Availability Period extending up to two years from the Closing Date or termination of the related TRS Confirmation. No specific principal amount or other quantitative financial metrics are disclosed in the filing.

  • ·Agreement effective April 29, 2026; SEC filing date April 30, 2026
  • ·Senior Notes issued pursuant to Indenture dated April 13, 2021, supplemented April 20, 2021
  • ·2025 OP Notes issued pursuant to Note Purchase Agreement dated October 10, 2025
  • ·Interest based on SOFR or Base Rate (highest of Overnight Bank Funding Rate +0.50%, Prime Rate, Daily Simple SOFR +1.00%)
Pelican Holdco, Inc.8-Kpositivemateriality 9/10

30-04-2026

Greenland Energy Company (Nasdaq: GLND) announced the pricing of a $70 million public offering of 17,500,000 shares (or pre-funded warrants) at $4.00 per share, each accompanied by a warrant exercisable at $5.00 per share and expiring in five years. Gross proceeds are expected to be $70 million before deducting placement agent fees and offering expenses, with closing anticipated on April 29, 2026, subject to customary conditions. Net proceeds will fund general corporate purposes, including working capital and operating expenses.

  • ·Warrants approved for listing on Nasdaq Global Market under symbol 'GLNDW', expected to commence trading April 28, 2026.
  • ·ThinkEquity acting as sole placement agent.
  • ·Registration statement on Form S-1 (File No. 333-294995) effective April 27, 2026.
RESMED INC8-Kpositivemateriality 9/10

30-04-2026

ResMed announced that Chief Financial Officer Brett Sandercock plans to retire effective May 4, 2026, after 27 years with the company including 20 as CFO, with Aaron Bloomer appointed as his successor from Exact Sciences. Bloomer brings 17 years of global finance experience, including roles at Baxter International and 3M, and is expected to support the 2030 strategy. ResMed reported Q3 FY26 results and is reiterating FY26 outlook with gross margins of 62-63%, SG&A at 19-20%, R&D at 6-7%, and effective tax rate of 21-23%.

  • ·Brett Sandercock to serve as advisor to CEO through end of 2027
  • ·ResMed envisions improving more than 500 million lives through sleep and breathing technologies

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

More from: US Material Events SEC 8-K Filings

🇺🇸 More from United States

View all →